María Soledad Undurraga

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

Hagop M. Kantarjian, Neil P. Shah, Jörge E. Cortes et al. · Blood · 2011 · 601 citations · Full text

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

Eduardo Magalhães Rego, Haesook T. Kim, Guillermo J. Ruíz‐Argüelles et al. · Blood · 2013 · 148 citations · Full text

Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

Antonio R. Lucena‐Araujo, Haesook T. Kim, Rafael Henriques Jácomo et al. · Annals of Hematology · 2014 · 74 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +9

Myelodysplastic syndromes in <scp>S</scp>outh <scp>A</scp>merica: A multinational study of 1080 patients

Carolina Belli, Ronald Feitosa Pinheiro, Yésica Bestach et al. · American Journal of Hematology · 2015 · 17 citations · Full text

Epidemiology Of Cancer, Genetic Epidemiology, Pathology +17

Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

Luisa Corrêa de Araújo Koury, Haesook T. Kim, María Soledad Undurraga et al. · Blood · 2024 · 10 citations